Can't forecast revenue. But I read that Biosante gets $5 million upon approval and a 10% royalty on sales. As for maket share, I read somewhere (can't remember where) but Bio-T-Gel could become the the favorite due to the improve delivery method, some of the competition transfers testosterone to the sexual partner (many partners don't want this).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.